Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||9.01%||12.95||0.7%||$905.25m|
|GILD||Gilead Sciences, Inc.||0.13%||68.15||1.0%||$461.62m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.92%||194.80||1.9%||$449.28m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.61%||528.75||2.7%||$364.34m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||181.65||2.0%||$341.36m|
|EXAS||EXACT Sciences Corp.||2.56%||125.01||18.1%||$192.21m|
|BNGO||Bionano Genomics, Inc.||3.17%||7.82||0.0%||$186.15m|
|ONTX||Onconova Therapeutics, Inc.||6.93%||7.56||1.8%||$181.22m|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.